HOB Competitors

688656 Stock

104.14 1.64 1.60%

HOB Biotech Group competes with Bengang Steel, Tianjin Capital, Sinocat Environmental, Hang Xiao, and Baoshan Iron; as well as few others. The company operates under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing HOB Biotech competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of HOB Biotech to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out HOB Biotech Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of HOB Biotech competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
95.66	104.02	112.38

Details

Intrinsic

Valuation

Low	Real	High
86.14	94.50	114.55

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as HOB Biotech. Your research has to be compared to or analyzed against HOB Biotech's peers to derive any actionable benefits. When done correctly, HOB Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in HOB Biotech Group.

HOB Biotech Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between HOB Biotech and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of HOB and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of HOB Biotech Group does not affect the price movement of the other competitor.

	000761	600874	688737	600477	600019	301355
000761		0.5	0.66	0.92	0.3	0.84	000761
600874	0.5		0.58	0.62	0.86	0.63	600874
688737	0.66	0.58		0.75	0.39	0.9	688737
600477	0.92	0.62	0.75		0.35	0.91	600477
600019	0.3	0.86	0.39	0.35		0.38	600019
301355	0.84	0.63	0.9	0.91	0.38		301355
	000761	600874	688737	600477	600019	301355

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between HOB Stock performing well and HOB Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze HOB Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
000761	2.86	0.71	0.27	(2.51)	2.24	(3.84)	9.84	(3.57)	18.04
600874	1.59	0.39	0.15	321.48	2.03	(1.71)	4.50	(2.77)	14.80
688737	3.18	0.85	0.19	5.27	3.67	(3.54)	6.70	(5.49)	29.14
600477	2.22	0.43	0.15	(57.64)	2.32	(2.88)	5.04	(3.62)	19.47
600019	1.68	0.43	0.14	(3.55)	2.05	(1.78)	4.80	(3.10)	17.37
301355	1.62	0.47	0.18	(1.28)	2.02	(1.99)	4.19	(2.15)	22.65

Unable to evaluate fundamental data of [000761.SHE, 600874.SHG, 688737.SHG, 600477.SHG, 600019.SHG, 301355.SHE] at this time. Please try again later

All Fundamental Data

HOB Biotech Competitive Analysis

The better you understand HOB Biotech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, HOB Biotech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across HOB Biotech's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	688656	000761	600874	688737	600477	600019	301355
	1.60 104.14 HOB	2.81 3.46 Bengang	0.33 6.08 Tianjin	0.66 21.08 Sinocat	1.07 2.78 Hang	2.33 7.02 Baoshan	0.08 12.84 Fujian
Market Volatility (90 Days Market Risk)	Very steady	Unstable	Slightly risky	Somewhat reliable	Risky	Slightly risky	Not too volatile
Market Performance (90 Days Performance)	Strong	Good	Good	Solid	Good	Good	Good
Odds of Financial Distress (Probability Of Bankruptcy)	Very Small	Low	Low	Low	Low	Very Small	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Hold	Hold	Strong Hold	Hold	Strong Hold	Hold	Cautious Hold
Net Asset	949.26 M	46.18 B	24.46 B	2.65 B	16.42 B	376.05 B	N/A
Profit Margin	0.09 %	(0.07) %	0.18 %	(0) %	0.03 %	0.03 %	0.04 %
EBITDA	78.62 M	(2.18 B)	2.18 B	(14.24 M)	599.13 M	29.78 B	70.18 M
Operating Margin	0.07 %	(0.13) %	0.35 %	(0.07) %	0.08 %	0.03 %	0.05 %
Current Valuation	7.23 B	22.31 B	16.38 B	2.45 B	11.51 B	174.72 B	2.54 B
Price To Book	8.97 X	1.06 X	1.02 X	1.55 X	1.32 X	0.75 X	1.67 X
Retained Earnings	162.13 M	(2.46 B)	5.65 B	107.48 M	1.81 B	89.66 B	N/A
Beta	0.21	0.64	0.25	0.44	0.43	0.65	N/A
Number Of Employees	550	14.34 K	2.25 K	595	8.29 K	43.13 K	1.85 K
Shares Outstanding	63.06 M	3.71 B	1.23 B	119.56 M	2.37 B	21.99 B	195.1 M
Cash Flow From Operations	102.69 M	4.33 B	992.01 M	(360.85 M)	(561.19 M)	25.3 B	N/A
Annual Yield	0 %	N/A	N/A	N/A	N/A	N/A	0.03 %
Total Debt	54.83 M	328 M	1.99 M	234.7 M	3.72 B	3.66 B	N/A
Return On Equity	0.0439	-0.22	0.0909	-9.0E-4	0.0465	0.0502	0.0327
Return On Asset	0.0266	-0.0482	0.037	-0.0123	0.0157	0.0187	0.0072
Book Value Per Share	12.95 X	3.36 X	6.08 X	11.04 X	2.21 X	9.02 X	7.89 X
Total Asset	949.26 M	46.18 B	24.46 B	2.65 B	16.42 B	376.05 B	N/A
Last Dividend Paid	0.4	N/A	0.17	N/A	0.05	0.31	0.1
Target Price	N/A	N/A	8.1	15.57	4.3	7.71	N/A
Shares Owned By Institutions	3.10 %	0.77 %	2.91 %	5.11 %	1.77 %	6.53 %	4.40 %
Market Capitalization	6.46 B	13.35 B	9.49 B	2.54 B	6.87 B	150.82 B	2.51 B
Price To Earnings To Growth	N/A	N/A	N/A	N/A	N/A	0.72 X	N/A
Price To Sales	16.11 X	0.25 X	1.98 X	1.72 X	0.73 X	0.45 X	1.95 X
Net Income	47.92 M	(1.74 B)	865.21 M	42.58 M	293.62 M	12.01 B	N/A
Earnings Per Share	0.56 X	(0.90) X	0.56 X	(0.11) X	0.11 X	0.43 X	0.27 X
Shares Owned By Insiders	77.69 %	86.38 %	62.93 %	53.46 %	44.54 %	67.56 %	61.26 %
Revenue	394.41 M	57.81 B	4.67 B	1.54 B	10.82 B	344.87 B	1.29 B
Working Capital	192.46 M	(5.96 B)	1.93 B	1.21 B	1.83 B	22.67 B	N/A
Gross Profit	320.16 M	164.04 M	1.54 B	448.26 M	1.32 B	22.76 B	N/A
Day Typical Price	103.8	3.48	6.09	20.95	2.8	6.99	12.81
Accumulation Distribution	72913.07	254704.0	193132.0	143799.0	702963.0	3.9 M	178706.0
Daily Balance Of Power	0.2543	(1.00)	0.1429	(0.14)	(0.43)	0.8	(0.02)
Period Momentum Indicator	1.64	(0.10)	0.02	(0.14)	(0.03)	0.16	(0.01)
Rate Of Daily Change	1.02	0.97	1.0	0.99	0.99	1.02	1.0
Day Median Price	103.63	3.49	6.1	20.88	2.81	6.98	12.8
Price Action Indicator	1.34	(0.08)	(0.01)	0.13	(0.04)	0.12	0.04
Coefficient Of Variation	284.81	522.23	573.22	511.51	668.48	575.67	557.69
Mean Deviation	6.3	2.86	1.59	3.18	2.22	1.68	1.62
Jensen Alpha	2.88	0.7095	0.3858	0.8485	0.4324	0.4312	0.469
Total Risk Alpha	2.72	0.6145	0.3312	0.7455	0.3612	0.3681	0.3988
Sortino Ratio	0.4303	0.2673	0.1547	0.1875	0.148	0.139	0.1837
Downside Variance	45.6	6.57	5.62	19.7	7.79	8.7	5.82
Standard Deviation	8.36	3.73	2.27	4.41	2.96	2.53	2.63
Kurtosis	0.1658	0.887	2.72	2.86	1.97	3.8	9.68
Potential Upside	20.0	9.84	4.5	6.7	5.04	4.8	4.19
Treynor Ratio	1.4	(2.51)	321.48	5.27	(57.64)	(3.55)	(1.28)
Maximum Drawdown	32.81	18.04	14.8	29.14	19.47	17.37	22.65
Variance	69.86	13.91	5.15	19.42	8.74	6.38	6.93
Market Risk Adjusted Performance	1.41	(2.50)	321.49	5.28	(57.63)	(3.54)	(1.27)
Risk Adjusted Performance	0.2881	0.1601	0.1452	0.1636	0.1262	0.1449	0.1495
Skewness	0.6828	0.841	(0.03)	0.0673	0.0507	(0.19)	0.0113
Semi Deviation	4.2	2.24	2.03	3.67	2.32	2.05	2.02
Information Ratio	0.3476	0.1837	0.1616	0.1889	0.1397	0.1622	0.1683
Value At Risk	(10.56)	(3.57)	(2.77)	(5.49)	(3.62)	(3.10)	(2.15)
Expected Short fall	(8.06)	(3.84)	(1.71)	(3.54)	(2.88)	(1.78)	(1.99)
Downside Deviation	6.75	2.56	2.37	4.44	2.79	2.95	2.41
Semi Variance	17.66	5.0	4.13	13.47	5.39	4.19	4.08

HOB Biotech Competition Performance Charts

Five steps to successful analysis of HOB Biotech Competition

HOB Biotech's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by HOB Biotech Group in relation to its competition. HOB Biotech's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of HOB Biotech in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact HOB Biotech's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to HOB Biotech Group, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your HOB Biotech position

In addition to having HOB Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Government Funds Thematic Idea Now

Government Funds

Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 48 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in HOB Stock

HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC